DSIP is studied in sleep architecture research, stress and ACTH-modulating pathway models, antioxidant pathway investigations, and opioid receptor interaction studies
The altered microbiome in non-secretors can increase the susceptibility of the host to bacterial, fungal, or viral infections, as well as kidney disease and chronic inflammatory diseases (126, 129)
Furthermore, the long-term effects on skeletal integrity remain unclear, with insufficient real-world data to guide personalized risk-benefit assessments
Patients typically notice appetite reduction within 35 days of the first injection
This applies even if the provider determines you are not a candidate for treatment
Gut microbiota produces biofilm-associated amyloids with potential for neurodegeneration